Al. Ruzycky, EFFECTS OF 17-BETA-ESTRADIOL AND PROGESTERONE ON MITOGEN-ACTIVATED PROTEIN-KINASE EXPRESSION AND ACTIVITY IN RAT UTERINE SMOOTH-MUSCLE, European journal of pharmacology, 300(3), 1996, pp. 247-254
Activation of mitogen-activated protein kinases (MAPKs) is a critical
event in mitogenic signal transduction. MAPKs are activated by tyrosin
e phosphorylation and translocate to different cellular compartments a
ffecting protein function and gene expression. MAPK expression and act
ivity was examined in uterine smooth muscle from rats pretreated with
estradiol-17 beta alone or with estradiol-17 beta and progesterone. MA
PK expression was detected by immunoblotting using erk1/2 antibodies.
MAPK activity was detected by measurement of the phosphorylation of a
MAPK-specific peptide sequence of myelin basic protein. Steroid treatm
ent caused a modest (20%) decline in erk 1 and 2 expression in membran
e and cytosolic fractions. Both estrogen and progesterone increased MA
PK tyrosine phosphorylation and membrane-associated MAPK activity. Ste
roid treatment increased cytosolic MAPK tyrosine phosphorylation, but
not enzymatic activity. These data suggest that gonadal steroid hormon
es, which stimulate uterine hypertrophy, may exert their hypertrophic
effects by increasing MAPK activity.